American Society of Nephrology | Kidney Week - [Session] Glomerular Diseases: 2020 Update (On-Demand)

Glomerular Diseases: 2020 Update

Glomerular Diseases: 2020 Update (On-Demand)

October 14, 2020 | 12:00 PM - 06:00 PM

Location: On-Demand

Session Description

This Early Program session includes approximately 11 hours of pre-recorded content which is made available to participants on October 14 at noon EDT through December 4, 2020.

Presentations

Management of Nephrotic Syndrome
12:00 PM - 12:00 PM
Rupali S. Avasare, MD

Rupali S. Avasare, MD

Pathology of FSGS and Membranous Nephropathy
12:00 PM - 12:00 PM
Cynthia C. Nast, MD, FASN

Cynthia C. Nast, MD, FASN

Cynthia C. Nast is Professor of Pathology at Cedars-Sinai Medical Center and the David Geffen School of Medicine at UCLA, and Director of Renal Pathology and Electron Microscopy at Cedars-Sinai Medical Center. She attended medical school at New York Medical College, and completed her pathology residency and renal pathology fellowship at Harbor-UCLA Medical Center. She has received the Churg Award from the Renal Pathology Society, presented educational courses in renal pathology for the ASN, ISN, United States and Canadian Academy of Pathology, and International Pediatric Nephrology Association, among others, and is a participant in multicenter grants studying glomerular disease and chronic interstitial nephritis in agricultural communities.

Management of Minimal Change Disease and FSGS
12:00 PM - 12:00 PM
J. Ashley Jefferson, MD, FASN

J. Ashley Jefferson, MD, FASN

Management of Membranous Nephropathy
12:00 PM - 12:00 PM
Laurence H. Beck, MD, PhD

Laurence H. Beck, MD, PhD

Glomerular Disease in Children
12:00 PM - 12:00 PM
Rasheed A. Gbadegesin, MD, MBBS, FASN

Rasheed A. Gbadegesin, MD, MBBS, FASN

Pathology and Classification of C3 Glomerulopathy and Thrombotic Microangiopathy
12:00 PM - 12:00 PM
Cynthia C. Nast, MD, FASN

Cynthia C. Nast, MD, FASN

Complement in C3 Glomerulopathy and Common Kidney Diseases
12:00 PM - 12:00 PM
Joshua M. Thurman, MD

Joshua M. Thurman, MD

Joshua M. Thurman, MD is the Temple Hoyne Buell Professor of Medicine in the Division of Nephrology and Hypertension at the University of Colorado. His laboratory studies the underlying causes of auto-immunity and inflammation of the kidney, and has developed several novel anti-inflammatory therapeutic agents. Projects are also underway that explore the link between inflammation and cancer. Dr. Thurman’s laboratory has also developed novel radiologic probes to detect and monitor renal inflammation by magnetic resonance imaging (MRI) and positron emission tomography (PET).

Precision Medicine in Glomerular Disease
12:00 PM - 12:00 PM
Sharon G. Adler, MD, FASN

Sharon G. Adler, MD, FASN

Chief, Division of Nephrology and Hypertension, Harbor-UCLA Medical Center Professor of Medicine, Geffen School of Medicine at UCLA

Pathology of Dysproteinemias
12:00 PM - 12:00 PM
Glen S. Markowitz, MD

Glen S. Markowitz, MD

Management of Dysproteinemias
12:00 PM - 12:00 PM
Jonathan Hogan, MD

Jonathan Hogan, MD

Dr. Jonathan Hogan is an Assistant Professor of Medicine, Division of Nephrology, at the Perelman School of Medicine, University of Pennsylvania, in Philadelphia, PA. He is the clinical director of the Penn Glomerular Disease Center and also runs the Penn Onconephrology Program. He is site-PI on multiple industry and NIH-sponsored trials and studies in glomerular diseases and diabetic nephropathy. He has published multiple peer-reviewed manuscripts and book chapters on glomerular diseases and onconephrology, and has been an invited speaker on these topics at regional, national and international meetings. Dr. Hogan was born and raised in Queens, New York. He received Bachelors Degrees in Philosophy and Biology at Fordham University in the Bronx, New York. He received his medical degree from the University of Pennsylvania in Philadelphia, PA, and completed his internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania. He then completed his fellowship in Nephrology at Columbia University Medical Center, and a subspecialty fellowship in Glomerular Diseases at the Columbia University Glomerular Center.

Management of ANCA-Associated Vasculitis
12:00 PM - 12:00 PM
Rachel B. Jones, MD, MBBS

Rachel B. Jones, MD, MBBS

APOL1: A Therapeutic Target in Glomerular Disease
12:00 PM - 12:00 PM
Jeffrey B. Kopp, MD, FASN

Jeffrey B. Kopp, MD, FASN

IgA Nephropathy
12:00 PM - 12:00 PM
Heather N. Reich, MD, PhD

Heather N. Reich, MD, PhD

Dr. Reich is a graduate of McGill University medical school. She completed her specialty training and PhD at the University of Toronto, where she is now an Associate Professor and holds the Gabor Zellerman Chair in nephrology research. Her clinical practice is based at the Toronto General Hospital where she directs the glomerulonephritis clinical and research programme. Her translational research is focused on disease progression in glomerulonephritis, with a specific interest in IgA nephropathy. She is a senior scientist at the Toronto General Research Institute. She is passionate about improving the care and outcomes of patients with glomerulonephritis and is a former co-director of the ASN glomerulonephritis precourse.

Glomerular Disease in Pregnancy
12:00 PM - 12:00 PM
Liz Lightstone, MBBS, PhD

Liz Lightstone, MBBS, PhD

Prof Lightstone is Prof of Renal Medicine at Imperial College London and practices her nephrology at the West London Renal and Transplant centre based at The Hammersmith Hospital. She trained in Cambridge University and London University and been on the Faculty of Imperial College since 1995. She has a long standing focus on immune mediated kidney disease, most notably lupus nephritis and has undertaken research into mechanisms and treatment with a strong focus on minimising steroid exposure by use of more targeted therapies such as B cell depletion. She has run and participated in several randomised controlled trials, and contributed to international guidelines. She also has developed clinical and research expertise in optimising pregnancies in women with kidney disease. She has run a joint renal obstetric clinic since 1996, overseeing the care of more than 900 women. Her research has focused on better diagnosis of pre eclampsia in such women as well as optimising care and prognosis - she was the founding national coordinator of the Renal Association Rare Renal Pregnancy and CKD registry and in 2019 was coauthor on the first ever guideline for the management of pregnancy in women with kidney disease - commissioned by the Renal Association and NICE assured.

Update on Diabetic Kidney Disease
12:00 PM - 12:00 PM
Katherine R. Tuttle, MD, FASN

Katherine R. Tuttle, MD, FASN

Katherine R. Tuttle, MD, FASN, FACP, FNKF, is Executive Director for Research at Providence Health Care, Co-Principal Investigator of the Institute of Translational Health Sciences and Professor of Medicine at the University of Washington. Dr. Tuttle earned her medical degree and completed her residency in Internal Medicine at Northwestern University School of Medicine in Chicago, Illinois. She was a fellow in Metabolism and Endocrinology at Washington University in St. Louis, Missouri. Her Nephrology fellowship training was performed at University of Texas Health Science Center in San Antonio, Texas. Dr. Tuttle’s major research interests are in clinical and translational science for diabetes and chronic kidney disease. She has published over 200 original research contributions and served two terms as Associate Editor for the Clinical Journal of the American Society of Nephrology and the American Journal of Kidney Disease. Dr. Tuttle has received many honors and awards including the Medal of Excellence from the American Association of Kidney Patients, Garbed Eknoyan Award from the National Kidney Foundation, the YWCA Woman of Achievement Award in Science, and two Outstanding Clinical Faculty Awards at the University of Washington. Dr. Tuttle served on the Board of Directors for the Kidney Health Initiative and has chaired numerous kidney and diabetes related working groups and committees for organizations including the NIDDK/NIH, the National Kidney Foundation, the American Society of Nephrology, the International Society of Nephrology, and the American Diabetes Association.

Management of Lupus Nephritis
12:00 PM - 12:00 PM
Brad H. Rovin, MD, FASN

Brad H. Rovin, MD, FASN

ASN's Mission

Contact ASN

The Latest on Twitter

Kidney Week

Glomerular Diseases: 2020 Update (On-Demand)

Glomerular Diseases: 2020 Update

Glomerular Diseases: 2020 Update (On-Demand)

October 14, 2020 | 12:00 PM - 06:00 PM

Session Description

Presentations

Rupali S. Avasare, MD

Management of Nephrotic Syndrome

Cynthia C. Nast, MD, FASN

Pathology of FSGS and Membranous Nephropathy

J. Ashley Jefferson, MD, FASN

Management of Minimal Change Disease and FSGS

Laurence H. Beck, MD, PhD

Management of Membranous Nephropathy

Rasheed A. Gbadegesin, MD, MBBS, FASN

Glomerular Disease in Children

Cynthia C. Nast, MD, FASN

Pathology and Classification of C3 Glomerulopathy and Thrombotic Microangiopathy

Joshua M. Thurman, MD

Complement in C3 Glomerulopathy and Common Kidney Diseases

Sharon G. Adler, MD, FASN

Precision Medicine in Glomerular Disease

Glen S. Markowitz, MD

Pathology of Dysproteinemias

Jonathan Hogan, MD

Management of Dysproteinemias

Rachel B. Jones, MD, MBBS

Management of ANCA-Associated Vasculitis

Jeffrey B. Kopp, MD, FASN

APOL1: A Therapeutic Target in Glomerular Disease

Heather N. Reich, MD, PhD

IgA Nephropathy

Liz Lightstone, MBBS, PhD

Glomerular Disease in Pregnancy

Katherine R. Tuttle, MD, FASN

Update on Diabetic Kidney Disease

Brad H. Rovin, MD, FASN

Management of Lupus Nephritis